Cargando…

Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa

INTRODUCTION: Cryptococcus causes 15% of AIDS-related deaths and in South Africa, with its high HIV burden, is the dominant cause of adult meningitis. Cryptococcal meningitis (CM) mortality is high, partly because patients enter care with advanced HIV disease and because of failure of integrated car...

Descripción completa

Detalles Bibliográficos
Autores principales: Quan, Vanessa, Toro-Silva, Sandra, Sriruttan, Charlotte, Chetty, Verushka, Chihota, Violet, Candfield, Sophie, Vassall, Anna, Grant, Alison D., Govender, Nelesh P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907845/
https://www.ncbi.nlm.nih.gov/pubmed/31830060
http://dx.doi.org/10.1371/journal.pone.0225742
_version_ 1783478610480332800
author Quan, Vanessa
Toro-Silva, Sandra
Sriruttan, Charlotte
Chetty, Verushka
Chihota, Violet
Candfield, Sophie
Vassall, Anna
Grant, Alison D.
Govender, Nelesh P.
author_facet Quan, Vanessa
Toro-Silva, Sandra
Sriruttan, Charlotte
Chetty, Verushka
Chihota, Violet
Candfield, Sophie
Vassall, Anna
Grant, Alison D.
Govender, Nelesh P.
author_sort Quan, Vanessa
collection PubMed
description INTRODUCTION: Cryptococcus causes 15% of AIDS-related deaths and in South Africa, with its high HIV burden, is the dominant cause of adult meningitis. Cryptococcal meningitis (CM) mortality is high, partly because patients enter care with advanced HIV disease and because of failure of integrated care following CM diagnosis. We evaluated pathways to hospital care, missed opportunities for HIV testing and initiation of care. METHODS: We performed a cross-sectional study at five public-sector urban hospitals. We enrolled adults admitted with a first or recurrent episode of cryptococcal meningitis. Study nurses conducted interviews, supplemented by a prospective review of medical charts and laboratory records. RESULTS: From May to October 2015, 102 participants were enrolled; median age was 40 years (interquartile range [IQR] 33.9–46.7) and 56 (55%) were male. In the six weeks prior to admission, 2/102 participants were asymptomatic, 72/100 participants sought care at a public-sector facility, 16/100 paid for private health care. The median time from seeking care to admission was 4 days (IQR, 0–27 days). Of 94 HIV-seropositive participants, only 62 (66%) knew their status and 41/62 (66%) had ever taken antiretroviral treatment. Among 13 participants with a known previous CM episode, none were taking fluconazole maintenance therapy. In-hospital management was mostly amphotericin B; in-hospital mortality was high (28/92, 30%). Sixty-four participants were discharged, 92% (59/64) on maintenance fluconazole, 4% (3/64) not on fluconazole and 3% (2/64) unknown. Twelve weeks post-discharge, 31/64 (48%) participants were lost to follow up. By 12 weeks post discharge 7/33 (21%) had died. Interviewed patients were asked if they were still on fluconazole, 11% (2/18) were not. CONCLUSIONS: Among hospitalised participants with CM, there were many missed opportunities for HIV care and linkage to ART prior to admission. Universal reflex CrAg screening may prompt earlier diagnosis of cryptococcal meningitis but there is a wider problem of timely linkage to care for HIV-seropositive people.
format Online
Article
Text
id pubmed-6907845
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69078452019-12-27 Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa Quan, Vanessa Toro-Silva, Sandra Sriruttan, Charlotte Chetty, Verushka Chihota, Violet Candfield, Sophie Vassall, Anna Grant, Alison D. Govender, Nelesh P. PLoS One Research Article INTRODUCTION: Cryptococcus causes 15% of AIDS-related deaths and in South Africa, with its high HIV burden, is the dominant cause of adult meningitis. Cryptococcal meningitis (CM) mortality is high, partly because patients enter care with advanced HIV disease and because of failure of integrated care following CM diagnosis. We evaluated pathways to hospital care, missed opportunities for HIV testing and initiation of care. METHODS: We performed a cross-sectional study at five public-sector urban hospitals. We enrolled adults admitted with a first or recurrent episode of cryptococcal meningitis. Study nurses conducted interviews, supplemented by a prospective review of medical charts and laboratory records. RESULTS: From May to October 2015, 102 participants were enrolled; median age was 40 years (interquartile range [IQR] 33.9–46.7) and 56 (55%) were male. In the six weeks prior to admission, 2/102 participants were asymptomatic, 72/100 participants sought care at a public-sector facility, 16/100 paid for private health care. The median time from seeking care to admission was 4 days (IQR, 0–27 days). Of 94 HIV-seropositive participants, only 62 (66%) knew their status and 41/62 (66%) had ever taken antiretroviral treatment. Among 13 participants with a known previous CM episode, none were taking fluconazole maintenance therapy. In-hospital management was mostly amphotericin B; in-hospital mortality was high (28/92, 30%). Sixty-four participants were discharged, 92% (59/64) on maintenance fluconazole, 4% (3/64) not on fluconazole and 3% (2/64) unknown. Twelve weeks post-discharge, 31/64 (48%) participants were lost to follow up. By 12 weeks post discharge 7/33 (21%) had died. Interviewed patients were asked if they were still on fluconazole, 11% (2/18) were not. CONCLUSIONS: Among hospitalised participants with CM, there were many missed opportunities for HIV care and linkage to ART prior to admission. Universal reflex CrAg screening may prompt earlier diagnosis of cryptococcal meningitis but there is a wider problem of timely linkage to care for HIV-seropositive people. Public Library of Science 2019-12-12 /pmc/articles/PMC6907845/ /pubmed/31830060 http://dx.doi.org/10.1371/journal.pone.0225742 Text en © 2019 Quan et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Quan, Vanessa
Toro-Silva, Sandra
Sriruttan, Charlotte
Chetty, Verushka
Chihota, Violet
Candfield, Sophie
Vassall, Anna
Grant, Alison D.
Govender, Nelesh P.
Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa
title Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa
title_full Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa
title_fullStr Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa
title_full_unstemmed Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa
title_short Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa
title_sort pathways to care and outcomes among hospitalised hiv-seropositive persons with cryptococcal meningitis in south africa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907845/
https://www.ncbi.nlm.nih.gov/pubmed/31830060
http://dx.doi.org/10.1371/journal.pone.0225742
work_keys_str_mv AT quanvanessa pathwaystocareandoutcomesamonghospitalisedhivseropositivepersonswithcryptococcalmeningitisinsouthafrica
AT torosilvasandra pathwaystocareandoutcomesamonghospitalisedhivseropositivepersonswithcryptococcalmeningitisinsouthafrica
AT sriruttancharlotte pathwaystocareandoutcomesamonghospitalisedhivseropositivepersonswithcryptococcalmeningitisinsouthafrica
AT chettyverushka pathwaystocareandoutcomesamonghospitalisedhivseropositivepersonswithcryptococcalmeningitisinsouthafrica
AT chihotaviolet pathwaystocareandoutcomesamonghospitalisedhivseropositivepersonswithcryptococcalmeningitisinsouthafrica
AT candfieldsophie pathwaystocareandoutcomesamonghospitalisedhivseropositivepersonswithcryptococcalmeningitisinsouthafrica
AT vassallanna pathwaystocareandoutcomesamonghospitalisedhivseropositivepersonswithcryptococcalmeningitisinsouthafrica
AT grantalisond pathwaystocareandoutcomesamonghospitalisedhivseropositivepersonswithcryptococcalmeningitisinsouthafrica
AT govenderneleshp pathwaystocareandoutcomesamonghospitalisedhivseropositivepersonswithcryptococcalmeningitisinsouthafrica
AT pathwaystocareandoutcomesamonghospitalisedhivseropositivepersonswithcryptococcalmeningitisinsouthafrica